Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ford

Showing results (1371-1380 of 1,411) with videos related to

Pageof 142
Sort By:
Nature|May 13, 2011
Profound early control of highly pathogenic SIV by an effector memory T-cell vaccineScott G Hansen, Julia C Ford, Matthew S Lewis, et al.
Trials|August 21, 2019
Treatment of irritable bowel syndrome with diarrhoea using titrated ondansetron (TRITON): study protocol for a randomised controlled trialDavid Gunn, Ron Fried, Rabia Lalani, et al.
Journal of Psychosomatic Research|July 4, 2021
The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative studyNuno Ferreira, Antonina Mikocka-Walus, Miranda A L van Tilburg, et al.
Technology in Cancer Research & Treatment|April 25, 2020
Low-Dose Image-Guided Pediatric CNS Radiation Therapy: Final Analysis From a Prospective Low-Dose Cone-Beam CT Protocol From a Multinational Pediatrics ConsortiumSara R Alcorn, Xian Chiong Zhou, Casey Bojechko, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Human birth tissue products as a non-opioid medicine to inhibit post-surgical painChi Zhang, Qian Huang, Neil C Ford, et al.
Trials|July 8, 2022
Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary careSarah L Alderson, Alexandra Wright-Hughes, Alexander C Ford, et al.
Neurology|November 26, 2003
Contrast letter acuity as a visual component for the Multiple Sclerosis Functional CompositeL J Balcer, M L Baier, J A Cohen, et al.
Plos One|January 24, 2019
Cytomegalovirus vectors expressing Plasmodium knowlesi antigens induce immune responses that delay parasitemia upon sporozoite challengeScott G Hansen, Jennie Womack, Isabel Scholz, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|August 27, 2024
Low-dose amitriptyline for irritable bowel syndrome: a qualitative study of patients' and GPs' views and experiencesEmma J Teasdale, Hazel A Everitt, Sarah L Alderson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 19, 2011
Protein microarray analysis of mammary epithelial cells from obese and nonobese women at high risk for breast cancer: feasibility dataPatrick G Pilie, Catherine Ibarra-Drendall, Michelle M Troch, et al.
Pageof 142

Showing results (1371-1380 of 1,411) with videos related to

Sort By:
Pageof 142
Nature|May 13, 2011
Profound early control of highly pathogenic SIV by an effector memory T-cell vaccineScott G Hansen, Julia C Ford, Matthew S Lewis, et al.
Trials|August 21, 2019
Treatment of irritable bowel syndrome with diarrhoea using titrated ondansetron (TRITON): study protocol for a randomised controlled trialDavid Gunn, Ron Fried, Rabia Lalani, et al.
Journal of Psychosomatic Research|July 4, 2021
The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative studyNuno Ferreira, Antonina Mikocka-Walus, Miranda A L van Tilburg, et al.
Technology in Cancer Research & Treatment|April 25, 2020
Low-Dose Image-Guided Pediatric CNS Radiation Therapy: Final Analysis From a Prospective Low-Dose Cone-Beam CT Protocol From a Multinational Pediatrics ConsortiumSara R Alcorn, Xian Chiong Zhou, Casey Bojechko, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Human birth tissue products as a non-opioid medicine to inhibit post-surgical painChi Zhang, Qian Huang, Neil C Ford, et al.
Trials|July 8, 2022
Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary careSarah L Alderson, Alexandra Wright-Hughes, Alexander C Ford, et al.
Neurology|November 26, 2003
Contrast letter acuity as a visual component for the Multiple Sclerosis Functional CompositeL J Balcer, M L Baier, J A Cohen, et al.
Plos One|January 24, 2019
Cytomegalovirus vectors expressing Plasmodium knowlesi antigens induce immune responses that delay parasitemia upon sporozoite challengeScott G Hansen, Jennie Womack, Isabel Scholz, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|August 27, 2024
Low-dose amitriptyline for irritable bowel syndrome: a qualitative study of patients' and GPs' views and experiencesEmma J Teasdale, Hazel A Everitt, Sarah L Alderson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 19, 2011
Protein microarray analysis of mammary epithelial cells from obese and nonobese women at high risk for breast cancer: feasibility dataPatrick G Pilie, Catherine Ibarra-Drendall, Michelle M Troch, et al.
Pageof 142